23 Apr 2021asset acquisition disposition▲ Good
Verde Bio closed another royalty acquisition for $430,000, continuing its rapid roll-up pace through the spring of 2021.
Announcements, explained
Each one in plain English, with the numbers worked through for a shareholder.
16 Apr 2021asset acquisition disposition▲ Good
Verde Bio closed another royalty acquisition, its largest single deal yet at nearly $498,000.
9 Apr 2021asset acquisition disposition▲ Good
Verde Bio closed two more royalty acquisitions from separate individual sellers in the same week, for $309,975 and $133,000.
6 Apr 2021asset acquisition disposition▲ Good
Verde Bio closed a larger royalty acquisition, for $380,562 cash -- a step up in deal size from its earlier ~$130-150K purchases.
5 Apr 2021asset acquisition disposition▲ Good
Verde Bio closed another mineral and royalty acquisition, for $152,000 cash.
29 Mar 2021asset acquisition disposition▲ Good
Verde Bio closed another royalty-interest acquisition, for $150,000 cash.
25 Mar 2021asset acquisition disposition▲ Good
Verde Bio closed another small mineral-interest acquisition, for $127,500 cash.
11 Mar 2021asset acquisition disposition▲ Good
The $150,000 royalty acquisition announced in February closed.
2 Mar 2021material agreement▲ Good
Verde Bio agreed to buy more royalty interests, this time for $150,000 cash rather than stock -- its business model shifting toward cash-funded acquisitions as it grew.
11 Feb 2021capital raising announcement▼ Bad
Verde Bio took another Power Up Lending Group convertible note, $43,500 on the same 12%/42%-of-market terms - filed as an identical duplicate 8-K under a separate accession number the same day, so this may represent one note counted twice rather than two.
11 Feb 2021capital raising announcement▼ Bad
Verde Bio took another Power Up Lending Group convertible note, $43,500 on the same 12%/42%-of-market terms - filed as an identical duplicate 8-K under a separate accession number the same day, so this may represent one note counted twice rather than two.
25 Jan 2021capital raising announcement▼ BadMajor
Verde Bio added a third toxic-note lender, Power Up Lending Group: a $55,500 convertible note at 12% interest, convertible after 180 days at a 42% discount to market.
6 Jan 2021capital raising announcement▼ BadMajor
Verde Bio took on a new toxic-style lender alongside GHS: a $30,556 convertible note from Quick Capital, LLC at 10% interest, convertible at a steep discount (the lesser of $0.01 or 50% of market).
17 Nov 2020capital raising announcement▼ Bad
Verde Bio took a fifth GHS Investments convertible note, $35,000 on the same 10%/60%-of-market terms, bringing this round of GHS notes to roughly $186,000 before their 2021 payoff.
1 Oct 2020material agreement▲ Good
Verde Bio agreed to buy more mineral and royalty interests from a private seller for 5 million shares, continuing to build its royalty portfolio.
28 Sept 2020capital raising announcement▼ Bad
Verde Bio took a fourth GHS Investments convertible note, $35,000 on the same 10%/60%-of-market terms.
30 July 2020material agreement▲ GoodMajor
Now renamed Verde Bio Holdings, the company made its first oil and gas move: agreeing to buy mineral and royalty interests from a private seller for 10 million shares of stock -- the start of its actual current business as a rolling acquirer of small oil and gas royalty packages.
4 June 2020capital raising announcement▼ BadMajor
Verde Bio lined up a $5 million GHS Investments equity line ahead of its oil-and-gas pivot, and separately issued 24.5 million shares to consultants and service providers - including 20 million shares to sole director and CEO Scott Cox, who approved his own grant.
7 May 2020material agreement● Neutral
The company signed another consulting agreement (with Lifetime Insurance & Risk Planning) for general corporate-growth advice, still before the pivot to oil and gas royalties was announced.
30 Mar 2020capital raising announcement▼ Bad
Appiphany took a third GHS Investments convertible note, $13,000 on the same 10%/60%-of-market terms.
12 Feb 2020capital raising announcement● NeutralMajor
Appiphany formed a hemp seed and genetics joint venture with Tsilaan, LLC and Kola Venture Group, taking a 25% stake for $300,000 cash plus 1.5 million shares issued to its partners - a concrete step on the hemp pivot floated weeks earlier.
3 Feb 2020capital raising announcement▼ Bad
Appiphany took a second GHS Investments convertible note, $68,000 on the same 10%/60%-of-market terms as the note three weeks earlier.
3 Feb 2020material agreement● Neutral
Under new leadership, the company (still named Appiphany) briefly explored a pivot toward the hemp industry, hiring Mustang Capital as a consultant on hemp-related acquisitions and ventures.
21 Jan 2020capital raising announcement▼ BadMajor
Appiphany took on its first GHS Investments convertible note, $35,000 at 10% interest, convertible at a 60% discount to market - the start of the toxic-note debt load that would later cost $715,000 to unwind in 2021.
12 Dec 2019business combination▲ GoodMajor
Scott Cox took voting control of the company (by then still Appiphany) through a purchase of super-voting Series A Preferred shares, replacing Robert Sargent as sole director -- the change-of-control event that set up the company's later pivot into oil and gas as Verde Bio Holdings.
3 May 2017listing compliance notice▼ Bad
VERDE BIO HOLDINGS, INC. withdrew a registration statement, abandoning the offering it covered.
24 Feb 2017listing compliance notice▼ Bad
VERDE BIO HOLDINGS, INC. withdrew a registration statement, abandoning the offering it covered.
18 May 2016material agreement● Neutral
Appiphany signed TOMS Shoes as a customer for its Watchdog brand-protection monitoring service, at $2,350/month.
26 Feb 2016material agreement▲ GoodMajor
Appiphany acquired key customer accounts and brand-protection/anti-counterfeiting technology assets from Media Convergence Group for 20 million shares -- its actual product line (Watchdog anti-counterfeiting monitoring) at the time, years before the pivot to oil and gas.
5 Mar 2013material agreement● Neutral
Appiphany renewed the consulting arrangement with Jon Trump for another 3-month term, again for 300,000 shares.